Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06272487
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-02-15
Brief Title:
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications KARDIA-3
Sponsor:
Alnylam Pharmaceuticals
Organization:
Alnylam Pharmaceuticals